Search Results 1401-1410 of 18700 for Relapse
This medicine will not cure MS, but it may slow some of the disabling effects and decrease the number of relapses of the disease. It should only be used ...
Inotuzumab Ozogamicin In Treating Younger Patients With Relapsed Or Refractory CD22 Positive B Acute Lymphoblastic Leukemia. Rochester, Minn. This phase II ...
Mayo Clinic's CAR-T Cell Therapy Program offers a new cancer immunotherapy that involves genetically modifying T cells to activate the immune system to ...
Find out about diagnosis and treatment of this cancer that has spread to the lymph nodes or other parts of the body.
... Relapsed FHWT. Rochester, Minn. The purpose of this study is to evaluate how ... (relapsed). Drugs used in chemotherapy regimens such as UH-3 ...
Fervenza, is that patients often relapse after they stop taking the drug, reducing the rate of remission and length of long-term kidney function. Many ...
Improving outcomes after follicular lymphoma diagnosis. Follicular lymphoma is a heterogeneous disease characterized by episodes of relapse and transformation.
Some cases of microscopic colitis improve within a few weeks without treatment, although relapse is common. ... This medication decreases inflammation in the ...
The purose of this study is to evaluate the effiectiveness, safety, and pharmacokinetics of tirabrutinib monotherapy in patients with relapsed or refractory ...
The exact prevalence of imperforate anus in the newborn population is unknown. Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.